• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Chase Corporation (Amendment)

    7/25/23 5:55:30 PM ET
    $CCF
    Building Products
    Consumer Discretionary
    Get the next $CCF alert in real time by email
    SC 13D/A 1 d502521dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

    § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 3)*

     

     

    Chase Corporation

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    16150R104

    (CUSIP Number)

    Secil Kantarci - O’Neil

    Choate, Hall & Stewart LLP, Two International Place, Boston, MA 02110

    (617) 248-5000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    July 21, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

     


    CUSIP No.   Page 2 of 9

     

      1.    

    Names of Reporting Persons.

     

    Peter R. Chase

      2.  

    Check the Appropriate Box if a Member of a Group

    (a)  ☐        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Source of Funds

     

    PF

      5.  

    Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      6.  

    Citizenship or Place of Organization

     

    United States

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With:

     

         7.     

    Sole Voting Power

     

    260,357

         8.   

    Shared Voting Power

     

    580,162

         9.   

    Sole Dispositive Power

     

    260,357

       10.   

    Shared Dispositive Power

     

    580,162

    11.    

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    840,519

    12.  

    Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

    13.  

    Percent of Class Represented by Amount in Row (11)

     

    8.9%

    14.  

    Type of Reporting Person

     

    IN

     

    (1)

    Based on 9,506,344 shares of common stock of the Issuer disclosed by the Issuer as outstanding as of June 30, 2023


    This Amendment No. 3 amends the Statement on Schedule 13D (the “Schedule 13D”) filed with the Securities and Exchange Commission on February 14, 2008 and as previously amended by Peter R. Chase with respect to shares of common stock, $0.10 par value per share, of Chase Corporation. The Schedule 13D remains in full force and effect, except as specifically amended by this Amendment No. 2 to Schedule 13D. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.

    ITEM 4. Purpose of Transaction.

    Item 4 of the Schedule 13D hereby amended and supplemented as follows:

    The information set forth in Item 6 of this Schedule 13D is incorporated herein by reference.

    ITEM 5. Interest in Securities of the Issuer.

    Subparts (a) to (b) of Item 5 of the Schedule 13D are amended and restated as follows:

    (a) Mr. Chase beneficially owns 840,519 shares of the Company’s stock, which represents approximately 8.9% of the 9,506,344 shares of the Company’s common stock reported by the Company to be outstanding as of June 30, 2023. Of the total shares beneficially owned, 260,357 shares are owned by Mr. Chase directly; 305,897 shares are owned by the Peter R. Chase Insurance Trust; 1,470 shares are owned by the Chase 2015 Irrevocable Trust; 44,038 shares are owned by the Peter R. Chase Trust; 17,359 shares are owned by the Peter R. Chase 2022 Qualified Annuity Trust #1; 61,398 shares are owned by the Peter R. Chase 2022 Qualified Annuity Trust #2; and 150,000 shares are owned by the Peter R. Chase 2022 Qualified Annuity Trust #3.

    (b) Mr. Chase has the sole power to vote and dispose 260,357 shares, and shares power to vote and dispose 580,162 shares of the Company’s common stock.

    ITEM 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

    Item 6 of the Schedule 13D is hereby amended and supplemented as follows:

    On July 21, 2023, Chase Corporation, a Massachusetts corporation (“Chase” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Formulations Parent Corporation, a Delaware corporation (“Parent”), Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the “Merger”).

    Voting Agreement

    On July 21, 2023, in connection with the execution of the Merger Agreement, Parent, the Company and the Reporting Person entered into a Voting Agreement (the “Voting Agreement”) pursuant to which the Reporting Person agreed, among other things, (i) to vote in favor of the approval of the Merger and the adoption of the Merger Agreement and (ii) to be bound by certain restrictions on hiring and soliciting employees and certain non-competition and non-disparagement obligations.

    ITEM 7. Material to be Filed as Exhibits.

     

    Exhibit Number    Description
    Exhibit 1    Voting Agreement, dated as of July 21, 2023, by and among Formulations Parent Corporation, Peter Chase and the other parties set forth on the signature pages thereto


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: July 25, 2023      

    /s/ Peter R. Chase

          Peter R. Chase
         
    Get the next $CCF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inogen Names Michael Bourque as New Chief Financial Officer

      Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu

      1/24/24 4:00:00 PM ET
      $CCF
      $INGN
      Building Products
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Chase Corporation Announces Completion of Acquisition by KKR and Welcomes Lance Reisman as Chairman of the Board of Directors

      Chase Corporation ("Chase" or the "Company"), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced the successful completion of its acquisition by affiliates of KKR, a leading global investment firm, for $127.50 per share. As a result of the completion of the transaction, Chase common stock has ceased trading and will no longer be listed on the NYSE American. "Today represents an important milestone for Chase in our journey to better serve our customers through strategic growth and innovation," said Adam Chase, President and Chief Executive Officer of Chase. "From the beginning, KKR was a strong cultural fit

      11/15/23 9:23:00 AM ET
      $CCF
      $KKR
      Building Products
      Consumer Discretionary
      Investment Managers
      Finance
    • Chase Corporation Announces October 6, 2023 Special Meeting Results

      Chase Corporation ("Chase" or the "Company") (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, held a special meeting of shareholders earlier today (the "Special Meeting") at which Chase shareholders approved the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement") dated July 21, 2023 by and among Chase, Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation ("Merger Sub"). Pursuant to the Merger Agreement, Merger Sub will merge with and into Chase, with Chase surviving as a wholly owned subsidiary of Parent (the "Merger"). Parent and Merger

      10/6/23 4:18:00 PM ET
      $CCF
      $KKR
      Building Products
      Consumer Discretionary
      Investment Managers
      Finance

    $CCF
    Leadership Updates

    Live Leadership Updates

    See more
    • Inogen Names Michael Bourque as New Chief Financial Officer

      Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu

      1/24/24 4:00:00 PM ET
      $CCF
      $INGN
      Building Products
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Chase Corporation Appoints Ellen Rubin to its Board of Directors

      Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced on July 14, 2022 that the Board of Directors elected Ellen Rubin to the Board, as an independent director, effective immediately. Additionally, she will serve as a member of Chase's Audit Committee. Peter Chase, Chairman of the Board, commented "We are thrilled to be adding Ellen Rubin's leadership, industry knowledge, and expertise to our Board of Directors as we continue to expand our business, drive scale, and deliver against our proven growth strategy. Ms. Rubin brings to our Board an extensi

      7/20/22 5:23:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal First Quarter 2021 Results

      WESTWOOD, Mass.--(BUSINESS WIRE)--Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the quarter ended November 30, 2020, the first quarter of its fiscal year 2021. Fiscal First Quarter Key Highlights Total Revenue of $67.2 million, up compared to $66.8 million in the prior year Gross Margin of 41%, up compared to 37% in the prior year Net Income of $10.8 million, up compared to $7.4 million in the prior year Adjusted EBITDA of $18.1 million, up compared to $14.7 million in the prior year

      1/7/21 4:05:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    SEC Filings

    See more

    $CCF
    Financials

    Live finance-specific insights

    See more
    • SEC Form 15-12G filed by Chase Corporation

      15-12G - CHASE CORP (0000830524) (Filer)

      11/27/23 6:01:05 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form EFFECT filed by Chase Corporation

      EFFECT - CHASE CORP (0000830524) (Filer)

      11/17/23 12:15:07 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form S-8 POS filed by Chase Corporation

      S-8 POS - CHASE CORP (0000830524) (Filer)

      11/15/23 5:23:59 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal First Quarter 2023 Results

      Revenue Increased 37.2% to $103 Million Year Over Year NuCera Business Integration Progressing, Elevating Company-Wide Results While Expanding Geographic Footprint and Specialized Product Offerings Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the first fiscal quarter ended November 30, 2022. Fiscal First Quarter Financial and Recent Operational Highlights Total Revenue grew 37.2% to $103 million, primarily attributed to inorganic growth from the NuCera business which was acquired in the first month of Q1 FY23

      1/5/23 5:01:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal Fourth Quarter 2022 Results

      Revenue Increased by 12.7% to $88 Million in Q4 FY22 compared to Q4 FY21 Gross Margin improved from first half of fiscal 2022 ending the year at 37.8% Declares Dividend of $1.00 Per Share Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced financial results for the fourth fiscal quarter ended August 31, 2022. The Company also announced a cash dividend of $1.00 per share to shareholders of record on November 30, 2022, payable on December 9, 2022. Fiscal Fourth Quarter Financial and Recent Operational Highlights Total Revenue grew 12.7% to $88

      11/10/22 8:59:00 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Acquires NuCera Solutions

      Transformative acquisition expands the Company's suite of specialty polymers and attractive polymerization technologies, advancing Chase Corp's portfolio of products, customer reach and strategic growth trajectory Chase Corporation (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced that it has entered into a definitive agreement to acquire NuCera Solutions, ("NuCera" or the "Company") from SK Capital (a private equity firm headquartered in New York). NuCera is a recognized global leader in the production and development of highly differentiated specialty polymers and polymerization technologies

      7/18/22 6:04:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Bourque Michael J. returned 9,738 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:25:46 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Debyle Thomas D. returned 3,886 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:22:37 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Peter R returned 840,519 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:20:32 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      11/22/23 4:25:56 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      9/11/23 8:23:55 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      9/8/23 9:17:41 AM ET
      $CCF
      Building Products
      Consumer Discretionary